5 Best Consistent Dividend Stocks to Buy Right Now

Key Takeaways

• McKesson price target cut to $1,000 from $1,040.
• CFO Britt Vitalone retiring after 20 years.
• Kenny Cheung becomes CFO on May 29, 2026.
• GLP‑1 cash‑pay price drop shifts prescriptions away from insurance.
• Wegovy and Zepbound growth may pressure FY27 EBIT.

Pulse Analysis

Dividend investors often gravitate toward healthcare distributors for their stable cash flows and reliable payouts. McKesson, the nation’s largest drug wholesaler, exemplifies this trend with a 3.11% yield and a history of consistent dividend growth. However, the sector is not immune to market dynamics; the recent dip in cash‑pay GLP‑1 pricing reflects broader pricing pressures that can erode margins, especially as insurers renegotiate terms. Understanding these nuances helps investors gauge whether the dividend’s safety margin remains intact.

The CFO transition adds another layer of complexity. Britt Vitalone’s two‑decade tenure provided continuity in financial strategy, and his departure may introduce short‑term uncertainty. Kenny Cheung’s appointment signals fresh leadership, but investors will watch his early decisions on cost control and capital allocation, particularly as McKesson navigates the FY27 EBIT outlook. A smooth handover could preserve investor confidence, while any missteps might trigger volatility in the stock’s price and dividend outlook.

From a broader market perspective, McKesson’s challenges mirror the evolving pharmaceutical distribution landscape, where specialty drugs like Wegovy and Zepbound drive volume but also bring pricing volatility. Analysts’ mixed signals—maintaining a Buy rating despite a lower price target—suggest that the dividend’s appeal may hinge on the company’s ability to adapt to these pricing shifts while maintaining earnings growth. For income‑focused portfolios, monitoring the interplay between executive changes, earnings guidance, and sector‑wide drug pricing trends will be essential to assess the long‑term viability of McKesson’s dividend promise.